Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
Abstract
The present invention provides methods for reducing pain in a subject in need of such pain reduction by delivering, e.g., intrathecally or epidurally, a volatile anesthetic dissolved in a solution comprising an extractive solvent, e.g., DMSO or NMP, in an amount effective to reduce pain. Chronic or acute pain may be treated, or the anesthetic may be delivered as a regional anesthesia to a subject to anesthetize a portion the subject prior to a surgery. In certain embodiments, isoflurane, halothane, enflurane, sevoflurane, desflurane, methoxyflurane, or mixtures thereof may be used. Dosing regimens including a one-time administration, continuous and/or periodic administration are contemplated.
Claims
exact text as granted — not AI-modified1 - 66 . (canceled)
67 . A method for reducing pain in a subject in need of such pain reduction, the method comprising administering to the subject a pharmacologically acceptable solution having a volatile anesthetic dissolved therein in an amount effective to reduce pain,
wherein the solution further comprises an extractive solvent in an amount effective to reduce volatility of the volatile anesthetic; wherein the solution is delivered to the subject by a route selected from the group consisting of mucosal, buccal, rectal, vaginal, and subcutaneous; and wherein the volatile anesthetic is selected from the group consisting of isoflurane, halothane, enflurane, sevoflurane, desflurane, methoxyflurane, and mixtures thereof.
68 . The method of claim 67 , wherein the extractive solvent is dimethyl sulfoxide (DMSO), dimethylformamide, dimethylacetamide, N-Methyl-2-pyrrolidone (NMP), dimethylisosorbide, ethanol, propanol, or isopropanol.
69 . The method of claim 67 , wherein the volatile anesthetic is the only analgesic agent present in the solution in an amount sufficient to reduce pain in the subject.
70 . The method of claim 67 , wherein the extractive solvent comprises from about 10% to about 75% of the solution.
71 . The method of claim 67 , wherein the extractive solvent comprises from about 10% to about 25% of the solution.
72 . The method of claim 67 , wherein the extractive solvent comprises from about 25% to about 75% of the solution.
73 . The method of claim 67 , wherein the pain is chronic pain.
74 . The method of claim 67 , wherein the pain is acute pain.
75 . The method of claim 67 , wherein the solution is delivered to anesthetize a portion of the subject prior to a surgery, during a surgery, or after a surgery.
76 . The method of claim 67 , wherein the volatile anesthetic is isoflurane.
77 . The method of claim 67 , wherein the volatile anesthetic is sevoflurane.
78 . The method of claim 67 , wherein the volatile anesthetic is methoxyflurane.
79 . The method of claim 67 , wherein the solution comprises from about 10% to about 99% v/v anesthetic in solution.
80 . The method of claim 79 , wherein the solution comprises from about 10% to about 75% v/v anesthetic in solution.
81 . The method of claim 79 , wherein the solution comprises from about 75% to about 99% v/v anesthetic in solution.
82 . The method of claim 67 , wherein the delivery of the solution is periodic.
83 . The method of claim 67 , wherein the delivery of the solution is a one-time event.
84 . The method of claim 67 , wherein the delivery of the solution is periodically administered to the subject on separate occasions.
85 . The method of claim 67 , wherein the reduction comprises elimination of pain perception of a portion of the body of the subject.
86 . The method of claim 67 , wherein the solution comprising the volatile anesthetic is sterile.
87 . The method of claim 67 , wherein the subject is a human.
88 . The method of claim 67 , wherein the subject is a mouse or a rat.
89 . The method of claim 67 , wherein the extractive solvent is DMSO or ethanol, and wherein the volatile anesthetic is isoflurane.
90 . The method of claim 89 , wherein the extractive solvent comprises from about 10% to about 50% of the solution.
91 . The method of claim 67 , wherein the extractive solvent is DMSO or ethanol, and wherein the volatile anesthetic is sevoflurane.
92 . The method of claim 91 , wherein the extractive solvent comprises from about 10% to about 50% of the solution.
93 . The method of claim 67 , wherein the pain reduction is achieved without substantially interfering with motor function or without inhibition of motor function.
94 . The method of claim 67 , wherein the solution is administered more than once and timed to achieve pain reduction without substantially interfering with motor function or without inhibition of motor function.Join the waitlist — get patent alerts
Track US2020253864A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.